The AESKULISA® Parvovirus B19 IgG and IgM tests are qualitative and quantitative immunoassays for the detection of human IgG and IgM antibodies in serum or plasma against Parvovirus B19. The AESKULISA® Parvovirus B19 IgM supports the detection of acute infections. The AESKULISA® Parvovirus B19 IgG allows the confirmation of pathogen contact and supports the determination of the immune status. The results can only be interpreted in conjunction with the clinical picture. A diagnosis should not be based solely on the results of the test performed, but should always be made taking into account all clinical and laboratory findings. Further tests should be carried out for confirmation. AESKULISA® immunoassays are suitable for use by healthcare professionals with appropriate professional training in the use of in vitro diagnostics.
6063
Parvovirus B19 IgM
The AESKULISA® Parvovirus B19 IgG and IgM tests are qualitative and quantitative immunoassays for the detection of human IgG and IgM antibodies in serum or plasma against Parvovirus B19. The AESKULISA® Parvovirus B19 IgM supports the detection of acute infections. The AESKULISA® Parvovirus B19 IgG allows the confirmation of pathogen contact and supports the determination of the immune status. The results can only be interpreted in conjunction with the clinical picture. A diagnosis should not be based solely on the results of the test performed, but should always be made taking into account all clinical and laboratory findings. Further tests should be carried out for confirmation. AESKULISA® immunoassays are suitable for use by healthcare professionals with appropriate professional training in the use of in vitro diagnostics.













